SKI Market

A+| A| A-|

Indian Indices

Sensex

75,527.95 1,695.40
( 2.30%)

Global Indices

Nasdaq

51,233.54 363.79
(0.72%)

Dow Jones

7,453.14 37.84
(0.51%)

Hang Seng

66,063.56 1,846.29
(2.88%)

Nikkei 225

10,460.24 156.36
(1.52%)

Forex

USD-INR

95.34 -0.07
(-0.08%)

EUR-INR

110.08 -0.10
(-0.09%)

GBP-INR

127.59 -0.01
(-0.01%)

JPY-INR

0.59 0.00
(-0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

National Standard (India) Ltd

Industry : Construction

BSE Code

ISIN Demat

Book Value()

504882

INE166R01015

141

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATIONSTD

246.28

2379.1

EPS(TTM)

Face Value()

Div & Yield %

4.83

Back

maruti suzuki india ltd

Beta Drugs consolidated net profit declines 4.80% in the December 2025 quarter

Feb 15,2026

Net profit of Beta Drugs declined 4.80% to Rs 8.52 crore in the quarter ended December 2025 as against Rs 8.95 crore during the previous quarter ended December 2024. Sales declined 1.16% to Rs 87.27 crore in the quarter ended December 2025 as against Rs 88.29 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	87.27	88.29	-1
OPM %	19.47	20.90	-
PBDT	14.86	17.55	-15
PBT	10.47	14.31	-27
NP	8.52	8.95	-5

75,527.95 1,695.40 ( 2.30%)

51,233.54 363.79 (0.72%)

7,453.14 37.84 (0.51%)

66,063.56 1,846.29 (2.88%)

10,460.24 156.36 (1.52%)

95.34 -0.07 (-0.08%)

110.08 -0.10 (-0.09%)

127.59 -0.01 (-0.01%)

0.59 0.00 (-0.20%)